Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2313417rdf:typepubmed:Citationlld:pubmed
pubmed-article:2313417lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2313417lifeskim:mentionsumls-concept:C0018823lld:lifeskim
pubmed-article:2313417lifeskim:mentionsumls-concept:C0010592lld:lifeskim
pubmed-article:2313417lifeskim:mentionsumls-concept:C0034428lld:lifeskim
pubmed-article:2313417pubmed:issue1lld:pubmed
pubmed-article:2313417pubmed:dateCreated1990-4-16lld:pubmed
pubmed-article:2313417pubmed:abstractTextSix patients required fluorinated quinolone therapy for a variety of infections after heart transplantation. In contrast to findings in a previous report, none of the patients showed any evidence of nephrotoxicity or required a significant change in cyclosporine dose during the treatment period.lld:pubmed
pubmed-article:2313417pubmed:languageenglld:pubmed
pubmed-article:2313417pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2313417pubmed:citationSubsetIMlld:pubmed
pubmed-article:2313417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2313417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2313417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2313417pubmed:statusMEDLINElld:pubmed
pubmed-article:2313417pubmed:issn0887-2570lld:pubmed
pubmed-article:2313417pubmed:authorpubmed-author:RobinsonJ AJAlld:pubmed
pubmed-article:2313417pubmed:authorpubmed-author:PifarreRRlld:pubmed
pubmed-article:2313417pubmed:authorpubmed-author:Costanzo-Nord...lld:pubmed
pubmed-article:2313417pubmed:authorpubmed-author:O'KeefeP JPJlld:pubmed
pubmed-article:2313417pubmed:authorpubmed-author:VenezioF RFRlld:pubmed
pubmed-article:2313417pubmed:issnTypePrintlld:pubmed
pubmed-article:2313417pubmed:volume9lld:pubmed
pubmed-article:2313417pubmed:ownerNLMlld:pubmed
pubmed-article:2313417pubmed:authorsCompleteYlld:pubmed
pubmed-article:2313417pubmed:pagination30-1lld:pubmed
pubmed-article:2313417pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2313417pubmed:meshHeadingpubmed-meshheading:2313417-...lld:pubmed
pubmed-article:2313417pubmed:meshHeadingpubmed-meshheading:2313417-...lld:pubmed
pubmed-article:2313417pubmed:meshHeadingpubmed-meshheading:2313417-...lld:pubmed
pubmed-article:2313417pubmed:meshHeadingpubmed-meshheading:2313417-...lld:pubmed
pubmed-article:2313417pubmed:meshHeadingpubmed-meshheading:2313417-...lld:pubmed
pubmed-article:2313417pubmed:meshHeadingpubmed-meshheading:2313417-...lld:pubmed
pubmed-article:2313417pubmed:meshHeadingpubmed-meshheading:2313417-...lld:pubmed
pubmed-article:2313417pubmed:articleTitlePatients receiving quinolones and cyclosporine after heart transplantation.lld:pubmed
pubmed-article:2313417pubmed:affiliationStritch School of Medicine, Loyola University of Chicago, Maywood, IL 60153.lld:pubmed
pubmed-article:2313417pubmed:publicationTypeJournal Articlelld:pubmed